Table of Content


1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Ovarian Cancer Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type
6.1 Epithelial Ovarian Cancer
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Germ Cell Ovarian Cancer
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Stromal Cell Ovarian Cancer
6.3.1 Market Trends
6.3.2 Market Forecast

7 Market Breakup by Treatment Type
7.1 Immunotherapy
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Chemotherapy
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Targeted Therapy
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Surgery
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast

8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Homecare
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Speciality Centre
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast

9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast

10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 AbbVie Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Amneal Pharmaceuticals Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.3 AstraZeneca plc
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Eli Lilly and Company
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 F. Hoffmann-La Roche AG
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 GSK plc
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Hikma Pharmaceuticals PLC
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Lupin Limited
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Pfizer Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Teva Pharmaceutical Industries Ltd.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Ovarian Cancer Market: Major Drivers and Challenges
Figure 2: Global: Ovarian Cancer Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Ovarian Cancer Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Ovarian Cancer Market: Breakup by Type (in %), 2021
Figure 5: Global: Ovarian Cancer Market: Breakup by Treatment Type (in %), 2021
Figure 6: Global: Ovarian Cancer Market: Breakup by End User (in %), 2021
Figure 7: Global: Ovarian Cancer Market: Breakup by Region (in %), 2021
Figure 8: Global: Ovarian Cancer (Epithelial Ovarian Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Ovarian Cancer (Epithelial Ovarian Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Ovarian Cancer (Germ Cell Ovarian Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Ovarian Cancer (Germ Cell Ovarian Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Ovarian Cancer (Stromal Cell Ovarian Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Ovarian Cancer (Stromal Cell Ovarian Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Ovarian Cancer (Immunotherapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Ovarian Cancer (Immunotherapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Ovarian Cancer (Chemotherapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Ovarian Cancer (Chemotherapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Ovarian Cancer (Targeted Therapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Ovarian Cancer (Targeted Therapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Ovarian Cancer (Surgery) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Ovarian Cancer (Surgery) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Ovarian Cancer (Other Treatment Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Ovarian Cancer (Other Treatment Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Ovarian Cancer (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Ovarian Cancer (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Ovarian Cancer (Homecare) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Ovarian Cancer (Homecare) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Ovarian Cancer (Speciality Centre) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Ovarian Cancer (Speciality Centre) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Ovarian Cancer (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Ovarian Cancer (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: North America: Ovarian Cancer Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: North America: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: United States: Ovarian Cancer Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: United States: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Canada: Ovarian Cancer Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Canada: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Asia-Pacific: Ovarian Cancer Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Asia-Pacific: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: China: Ovarian Cancer Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: China: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Japan: Ovarian Cancer Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Japan: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: India: Ovarian Cancer Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: India: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: South Korea: Ovarian Cancer Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: South Korea: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Australia: Ovarian Cancer Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Australia: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Indonesia: Ovarian Cancer Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Indonesia: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Others: Ovarian Cancer Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Others: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Europe: Ovarian Cancer Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Europe: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Germany: Ovarian Cancer Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Germany: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: France: Ovarian Cancer Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: France: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: United Kingdom: Ovarian Cancer Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: United Kingdom: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Italy: Ovarian Cancer Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Italy: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Spain: Ovarian Cancer Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Spain: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Russia: Ovarian Cancer Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Russia: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Others: Ovarian Cancer Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Others: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Latin America: Ovarian Cancer Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Latin America: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Brazil: Ovarian Cancer Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Brazil: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Mexico: Ovarian Cancer Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Mexico: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Others: Ovarian Cancer Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Others: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Middle East and Africa: Ovarian Cancer Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Middle East and Africa: Ovarian Cancer Market: Breakup by Country (in %), 2021
Figure 80: Middle East and Africa: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Global: Ovarian Cancer Industry: SWOT Analysis
Figure 82: Global: Ovarian Cancer Industry: Value Chain Analysis
Figure 83: Global: Ovarian Cancer Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Ovarian Cancer Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Ovarian Cancer Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: Ovarian Cancer Market Forecast: Breakup by Treatment Type (in Million US$), 2022-2027
Table 4: Global: Ovarian Cancer Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Ovarian Cancer Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Ovarian Cancer Market: Competitive Structure
Table 7: Global: Ovarian Cancer Market: Key Players